Hangzhou Concord Medical Products Co., Ltd., Xinfeiling Singfiller, one of the top ten brands of hyaluronic acid, is a high-tech enterprise specializing in the research and development, production and sales of medical biomaterials, and is well-known in the fields of anti-adhesion, hemostasis, and microplastic materials
In 2002, in Fuyang Xindeng, Hangzhou Concord Medical Products Co., Ltd. took its first step. So far, the curtain has opened the curtain of the ten-year development of Concord Healthcare. In 2003, Concord Medical moved to Fuyang Gaoqiao Industrial Park, and successively built 2 10,000-level purification workshops, 1 quality inspection center and 1 R&D center, 1 warehouse building and one dormitory building, initially realizing the transition from small and medium-sized enterprises to small and medium-sized enterprises.
In 2011, Concord Medical acquired Haina Medical (Hangzhou) Co., Ltd., with a total investment of 300 million yuan, and began to build a new base in Xiasha of Concord Medical, which has built a standardized plant of 17,000 square meters, 3 GMP purification workshops of 2,000 square meters, a logistics center of 4,000 square meters, and a R&D and quality inspection center of 1,000 square meters, which can produce more than 1,200 sets of various medical devices and achieve a production capacity of 2.5 billion yuan. As of 2013, Concord Medical has three production bases in Xiasha, Fuyang and Nanchang, eight medical marketing centers in Hangzhou, Beijing, Shanghai, Nanchang, Guangzhou, Chengdu, Chongqing and Fuzhou, two medical exhibition and training companies in Beijing and Shanghai, more than 400 employees in the group, an annual output of more than 2 million sets of various medical equipment, and annual sales of more than 500 million yuan, successfully realizing the transformation from the entrepreneurial stage to the rapid development stage.
At present, Concord Medical has eight series of products, more than 50 kinds of medical device products are sold to 30 provinces and cities every year, with more than 1,000 users, and some products are exported to more than 40 countries around the world, such as: Italy, Russia, Turkey, France, Brazil, Chile, Australia, Canada. As Hangzhou Concord Medical Products Co., Ltd., which is oriented towards the development of new composite and intelligent materials, its persistence is being recognized.
Concord Medical has built an international research and development platform for absorbable biomaterials, and has obtained more than 10 patents in the fields of anti-adhesion, hemostasis, microplastic materials, and basic materials for tissue engineering, and a number of patents are being declared. Of course, in addition to product research and development, strict quality control is also the foundation of the enterprise's survival, Concord Medical follows the quality policy of "quality first, management first, building a harmonious enterprise, and creating a concord brand", and the production workshop adopts contemporary advanced pharmaceutical process production lines and online monitoring equipment to ensure the continuous production of Class III medical devices and drug injection products that meet the requirements of the State Food and Drug Administration (CFDA) regulations and the EU MDD directive. With more and more honors, more and more new technologies, and more and more mature development models, Hangzhou Concord Medical Products Co., Ltd. is becoming a leader in the field of resorbable biomaterials in China step by step.
